|
End-of-day quote
Shenzhen S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 9.560 CNY | +1.92% |
|
+0.74% | +20.40% |
| Market Cap | 5.56B 829M 740M 689M 627M 1.18B 79.88B 1.19B 8.33B 3.24B 40.77B 3.11B 3.05B 131B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 5.39B 804M 717M 668M 608M 1.15B 77.45B 1.15B 8.08B 3.14B 39.53B 3.02B 2.95B 127B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +1.92% | ||
| 1 week | +0.74% | ||
| 1 month | +12.87% | ||
| 3 months | +15.18% | ||
| 6 months | -4.59% | ||
| Current year | +20.40% |
| 1 week | 9.44 |  | 9.84 |
| 1 month | 7.82 | | 10.43 |
| Current year | 7.08 | | 11.38 |
| 1 year | 7.08 | | 11.38 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 11/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 01/08/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 25/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 01/08/2019 |
Ying Yang
CHM | Chairman | 48 | 21/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 21/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.92% | +0.74% | +12.21% | +38.35% | 829M | |
| +0.02% | -3.52% | +36.11% | +111.11% | 1,019B | |
| -1.21% | -6.99% | +34.08% | +60.96% | 617B | |
| +1.12% | -0.20% | +13.62% | +80.24% | 464B | |
| -3.30% | -6.15% | +56.45% | +34.69% | 356B | |
| +0.93% | -1.83% | +21.65% | +41.43% | 333B | |
| +0.12% | -4.05% | +10.70% | +33.53% | 267B | |
| -0.89% | -5.83% | -7.00% | +7.91% | 244B | |
| -0.01% | -3.62% | +35.28% | +52.02% | 218B | |
| -0.08% | -4.98% | +28.34% | +93.61% | 179B | |
| Average | +0.38% | -4.08% | +24.14% | +55.38% | 369.8B | |
| Weighted average by Cap. | +0.44% | -3.63% | +28.50% | +68.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 147M 131M 122M 111M 209M 14.13B 210M 1.47B 573M 7.21B 551M 539M 23.18B | 1.21B 180M 160M 149M 136M 256M 17.31B 258M 1.81B 702M 8.84B 675M 660M 28.4B |
| Net income | 13.65M 2.04M 1.82M 1.69M 1.54M 2.9M 196M 2.92M 20.45M 7.96M 100M 7.64M 7.48M 322M | 92.73M 13.83M 12.34M 11.5M 10.46M 19.7M 1.33B 19.85M 139M 54.04M 680M 51.92M 50.8M 2.19B |
| Net Debt | 189M 28.2M 25.16M 23.44M 21.33M 40.17M 2.72B 40.47M 283M 110M 1.39B 106M 104M 4.46B | -169M -25.18M -22.46M -20.93M -19.04M -35.86M -2.42B -36.13M -253M -98.38M -1.24B -94.52M -92.48M -3.98B |
Employees
1,188
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CN¥9.560 | +1.92% | 33,479,841 |
| 29/09/26 | CN¥9.380 | -1.16% | 31,612,779 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
